ch-OSA* is a complex that triggers the biological pathways that produce collagen
If you are noticing signs of aging on the outside of the body, then you can be assured they are present on the inside too. Support regeneration of collagen, elastin, and keratin by using ch-OSA.
The Collagen ~ Beauty Relationship
Various Effects of Diminished Collagen
- Fine lines and wrinkles
- Dull, sagging skin
- Thinner, more brittle hair
- Weaker nails
Women have less collagen than men.
Collagen in women decreases by 1% per year in exposed and unexposed skin. †
Keratin diminishes with age. †
After menopause, things get even worse …
- 30% of skin collagen declines in first 5 years. †
- Skin thickness shrinks 1.13% per year †
- Skin elasticity decreases 0.55% per year †
Calomme et al. Chapt. in Roussel et al, Trace Elements in Man and Animals 10. 2002:1111-1113.
Randomized, Double-Blind, Placebo-Controlled Studies of the Effects of Oral ch-OSA on Skin, Hair, Nails, and Joints
50 women with photodamaged facial skin were administered ch-OSA (n = 25) or placebo (n = 25) for 20 weeks.
Barel et al. Arch Dermatol Res. 2005 Oct;297(4):147-153.
48 women (18-65) with fine hair were administered ch-OSA (n = 24) or placebo (n = 24) for 36 weeks.
Wickett et al. Presentation at Fifth International Congress of Hair Research; June 13-16, 2007; Vancouver, BC, Canada. Wickett et al. Arch Dermatol Res. 2007 Dec;299(10):499-505.
Regular orthosilicic acid is highly unstable and forms polymers. The polymers are too large for the human body to absorb. ch-OSA patented “choline stabilization” technology prevents polymers from forming, ensuring optimal absorption. †Barel et al. Arch Dermatol Res. 2005 Oct;297(4):147-153.
Geusens et al. BMC Musculoskelet Disord. 2017 Jan 5;18(1):2
CASE STUDY DISCLAIMER: Case studies represent results of one participant. The reader should weigh these results with other scientific data and should not expect the same results as those found in the case studies alone.
Regrowth of Hair Lost (Male)
One of nine male Asian subjects (15-54 years old) in a pilot study on the efficacy of ch-OSA management of hair loss (2 x 5 mg Si/day)
Chan G. Paper presented at: 17th Regional Conference of Dermatology; September 13-16, 2006; Bali, Indonesia.
*These statements have not been evaluated by the Food and Drug Administration. This product is not intended to diagnose, treat, cure, or prevent any disease.